Atherton Lane Advisers’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | $395K | Buy |
3,900
+79
| +2% | +$8K | 0.02% | 153 |
|
|
2015
Q3 | $375K | Buy |
3,821
+753
| +25% | +$73.9K | 0.02% | 155 |
|
|
2015
Q2 | $359K | Sell |
3,068
-4,285
| -58% | -$501K | 0.02% | 164 |
|
|
2015
Q1 | $722K | Sell |
7,353
-600
| -8% | -$58.9K | 0.04% | 143 |
|
|
2014
Q4 | $750K | Buy |
7,953
+118
| +2% | +$11.1K | 0.04% | 147 |
|
|
2014
Q3 | $834K | Sell |
7,835
-279
| -3% | -$29.7K | 0.05% | 143 |
|
|
2014
Q2 | $673K | Sell |
8,114
-125
| -2% | -$10.4K | 0.04% | 160 |
|
|
2014
Q1 | $584K | Hold |
8,239
| – | – | 0.04% | 97 |
|
|
2013
Q4 | $619K | Buy |
8,239
+72
| +0.9% | +$5.41K | 0.04% | 95 |
|
|
2013
Q3 | $513K | Buy |
8,167
+117
| +1% | +$7.35K | 0.04% | 90 |
|
|
2013
Q2 | $413K | Buy |
+8,050
| New | +$413K | 0.03% | 98 |
|